Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04276532 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus

StatusActive, Not Recruiting
PhaseNot applicable
Started2020-02-13
View on ClinicalTrials.gov ↗
Aim To investigate the effect of sentinel lymph node (SLN) sampling on the prognosis of patients with middle-high risk endometrial cancer obviously confined to the uterus before surgery.

Amendment record

Amended 8 times since 2020-02-17; most recent filed 2026-05-08. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.

2026-05-08
Amendment Study Status, Oversight, Study Description, Arms and Interventions, Outcome Measures, Eligibility, Contacts/Locations v8
2025-02-15
Amendment RecruitingActive, Not Recruiting Study Status, Sponsor/Collaborators, Oversight, Contacts/Locations v7
2024-04-22
Amendment Study Status v6
2023-03-26
Amendment Study Status v5
2022-03-24
Amendment Study Status v4
2021-08-17
Amendment Study Status, Sponsor/Collaborators, Contacts/Locations v3
2020-10-22
Amendment Study Status, Arms and Interventions v2
2020-02-25
Amendment Not Yet RecruitingRecruiting Study Status, Contacts/Locations v1
2020-02-17
Original filing
Trial Details
NCT Number NCT04276532
Lead Sponsor Xiaojun Chen
Collaborators: Fudan University, Tongji Hospital, West China Second University Hospital, Sun Yat-Sen University Cancer Center, Chongqing University Cancer Hospital
Conditions Middle-high Risk Endometrial Cancer, Sentinel Lymph Node Sampling, Prognosis
Enrollment 780 participants
Start Date 2020-02-13
Primary Completion 2027-01-26 (estimated)
Study Completion 2030-02-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-12